Granulocyte colony-stimulating factor negatively regulates Toll-like receptor agonist-induced cytokine production in human neutrophils

Archives of Biochemistry and Biophysics

Volumn 495, Issue 2, 2010, Pages 144-151

  Fukuzono, Shunsuke ^a   Kato, Takayuki ^a   Fujita, Hisakazu ^a   Watanabe, Norifumi ^a   Kitagawa, Seiichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

G CSF; Neutrophil; Proinflammatory cytokines; STAT3; Toll like receptor

Indexed keywords

I KAPPA B ALPHA; INTERLEUKIN 8; JANUS KINASE 2; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; N PALMITOYL[2,3 BIS(PALMITOYLOXY)PROPYL]CYSTEINYLSERYLLYSYLLYSINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-8; JANUS KINASE 2; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; NEUTROPHILS; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77049083806     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2010.01.005     Document Type: Article

References (42)

1. Demetri G.D., and Griffin J.D. Blood 78 (1991) 2791-2808
2. Kitagawa S., Yuo A., Souza L.M., Saito M., Miura Y., and Takaku F. Biochem. Biophys. Res. Commun. 144 (1987) 1143-1146
3. Ohsaka A., Kitagawa S., Sakamoto S., Miura Y., Takanashi N., Takaku F., and Saito M. Blood 74 (1989) 2743-2748
4. Kato T., and Kitagawa S. Int. J. Hematol. 84 (2006) 205-209
5. Nakamae-Akahori M., Kato T., Masuda S., Sakamoto E., Kutsuna H., Hato F., Nishizawa Y., Hino M., and Kitagawa S. Immunology 119 (2006) 393-403
6. Hasegawa T., Suzuki K., Sakamoto C., Ohta K., Nishiki S., Hino M., Tatsumi N., and Kitagawa S. Blood 101 (2003) 1164-1171
7. Görgen I., Hartung T., Leist M., Niehorster M., Tiegs G., Uhlig S., Weitzel F., and Wendel A. J. Immunol. 149 (1992) 918-924
8. Hartung T., Döcke W.D., Gantner F., Krieger G., Sauer A., Stevens P., Volk H.D., and Wendel A. Blood 85 (1995) 2482-2489
9. Boneberg E.M., Hareng L., Gantner F., Wendel A., and Hartung T. Blood 95 (2000) 270-276
10. Nishiki S., Hato F., Kamata N., Sakamoto E., Hasegawa T., Kimura-Eto A., Hino M., and Kitagawa S. Am. J. Physiol. Cell Physiol. 286 (2004) C1302-C1311
11. Hayashi F., Means T.K., and Luster A.D. Blood 102 (2003) 2660-2669
12. Kurt-Jones E.A., Mandell L., Whitney C., Padgett A., Gosselin K., Newburger P.E., and Finberg R.W. Blood 100 (2002) 1860-1868
13. Aomatsu K., Kato T., Fujita H., Hato F., Oshitani N., Kamata N., Tamura T., Arakawa T., and Kitagawa S. Immunology 123 (2008) 171-180
14. Cassatella M.A., Tamassia N., Crepaldi L., McDonald P.P., Ear T., Calzetti F., Gasperini S., Zanderigo F., and Bazzoni F. Eur. J. Immunol. 35 (2005) 1877-1885
15. Wang J.P., Bowen G.N., Padden C., Cerny A., Finberg R.W., Newburger P.E., and Kurt-Jones E.A. Blood 112 (2008) 2028-2034
16. Kato T., Sakamoto E., Kutsuna H., Kimura-Eto A., Hato F., and Kitagawa S. J. Biol. Chem. 279 (2004) 31076-31080
17. Strassheim D., Asehnoune K., Park J.S., Kim J.Y., He Q., Richter D., Kuhn K., Mitra S., and Abraham E. J. Immunol. 172 (2004) 5727-5733
18. Inaba M., Takahashi T., Kumeda Y., Kato T., Hato F., Yutani Y., Goto H., Nishizawa Y., and Kitagawa S. Clin. Exp. Rheumatol. 26 (2008) 52-60
19. Suzuki K., Hino M., Hato F., Tatsumi N., and Kitagawa S. Blood 93 (1999) 341-349
20. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. Proc. Natl. Acad. Sci. USA 98 (2001) 13681-13686
21. Kutsuna H., Suzuki K., Kamata N., Kato T., Hato F., Mizuno K., Kobayashi H., Ishii M., and Kitagawa S. Am. J. Physiol. Cell Physiol. 286 (2004) C55-C64
22. Cloutier A., Ear T., Blais-Charron E., Dubois C.M., and McDonald P.P. J. Leukoc. Biol. 81 (2007) 567-577
23. Kato T., Noma H., Kitagawa M., Takahashi T., Oshitani N., and Kitagawa S. J. Interferon Cytokine Res. 28 (2008) 235-243
24. Suzuki K., Hino M., Kutsuna H., Hato F., Sakamoto C., Takahashi T., Tatsumi N., and Kitagawa S. J. Immunol. 167 (2001) 5940-5947
25. Neumann M., and Naumann M. FASEB J. 21 (2007) 2642-2654
26. Lee H., Herrmann A., Deng J.H., Kujawski M., Niu G., Li Z., Forman S., Jove R., Pardoll D.M., and Yu H. Cancer Cell 15 (2009) 283-293
27. Zhong H., May M.J., Jimi E., and Ghosh S. Mol. Cell 9 (2002) 625-636
28. Levitzki A. Pharmacol. Ther. 82 (1999) 231-239
29. Kim S.O., Sheikh H.I., Ha S.D., Martins A., and Reid G. Cell. Microbiol. 8 (2006) 1958-1971
30. Cloutier A., Ear T., Borissevitch O., Larivée P., and McDonald P.P. J. Immunol. 171 (2003) 3751-3761
31. Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O., Metin A., and Karasuyama H. Nature 448 (2007) 1058-1062
32. Holland S.M., DeLeo F.R., Elloumi H.Z., Hsu A.P., Uzel G., Brodsky N., Freeman A.F., Demidowich A., Davis J., Turner M.L., Anderson V.L., Darnell D.N., Welch P.A., Kuhns D.B., Frucht D.M., Malech H.L., Gallin J.I., Kobayashi S.D., Whitney A.R., Voyich J.M., Musser J.M., Woellner C., Schäffer A.A., Puck J.M., and Grimbacher B. N. Engl. J. Med. 357 (2007) 1608-1619
33. El Kasmi K.C., Holst J., Coffre M., Mielke L., de Pauw A., Lhocine N., Smith A.M., Rutschman R., Kaushal D., Shen Y., Suda T., Donnelly R.P., Myers Jr. M.G., Alexander W., Vignali D.A., Watowich S.S., Ernst M., Hilton D.J., and Murray P.J. J. Immunol. 177 (2006) 7880-7888
34. de Jonge W.J., van der Zanden E.P., The F.O., Bijlsma M.F., van Westerloo D.J., Bennink R.J., Berthoud H.R., Uematsu S., Akira S., van den Wijngaard R.M., and Boeckxstaens G.E. Nat. Immunol. 6 (2005) 844-851
35. Kano A., Wolfgang M.J., Gao Q., Jacoby J., Chai G.X., Hansen W., Iwamoto Y., Pober J.S., Flavell R.A., and Fu X.Y. J. Exp. Med. 198 (2003) 1517-1525
36. Sano S., Itami S., Takeda K., Tarutani M., Yamaguchi Y., Miura H., Yoshikawa K., Akira S., and Takeda J. EMBO J. 18 (1999) 4657-4668
37. Fuxman Bass J.I., Alvarez M.E., Gabelloni M.L., Vermeulen M.E., Amaral M.M., Geffner J.R., and Trevani A.S. Mol. Immunol. 46 (2008) 37-44
38. Tamassia N., Calzetti F., Ear T., Cloutier A., Gasperini S., Bazzoni F., McDonald P.P., and Cassatella M.A. Eur. J. Immunol. 37 (2007) 2627-2634
39. Sakamoto E., Hato F., Kato T., Sakamoto C., Akahori M., Hino M., and Kitagawa S. J. Leukoc. Biol. 78 (2005) 301-309
40. Tamassia N., Calzetti F., Menestrina N., Rossato M., Bazzoni F., Gottin L., and Cassatella M.A. Int. Immunol. 20 (2008) 535-541
41. Vincent M.E., Foote M., and Morstyn G. Pharmacology of filgrastim (r-metHuG-CSF). In: Morstyn G., and Dexter T.M. (Eds). Filgrastim (r-metHuG-CSF) in Clinical Practice (1994), Marcel Dekker Inc., New York 33-50
42. Hasenclever D., and Sextro M. Bone Marrow Transplant. 17 (1996) S28-S33